SIBN earnings: next report 2026-08-03, real EPS beat/miss history, analyst consensus Buy, P/E -43.08. Updated 2026-07-23.
SI-BONE (SIBN) Research Hub
SI-BONE (SIBN) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 18.38 USD (-0.16%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -43.08, market cap 0.74B. This hub links to the full technical, earnings and options research available for SIBN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.38 USD (-0.16%) |
| 52-week range | 15.04 USD – 20.05 USD |
| Trend regime | Range |
| 14-day RSI | 46.9 (Neutral) |
| Trailing P/E | -43.08 |
| Market cap | 0.74B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for SIBN
Covered Call on SIBN: how it works, illustrative setup around the real 18.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SIBN: how it works, illustrative setup around the real 18.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SIBN: how it works, illustrative setup around the real 18.38 USD price, max profit/loss, breakeven and when to use it. Educational.
SIBN technical analysis: range, last 18.38 USD, RSI 46.9, 52w range 15.04 USD–20.05 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SIBN in?
SI-BONE (SIBN) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SIBN in an uptrend or downtrend?
As of 2026-09-11, SIBN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SIBN's trailing P/E ratio?
SIBN's trailing P/E is -43.08, with a market cap of 0.74B. See the earnings research page for full valuation detail.
When does SIBN next report earnings?
SIBN is next scheduled to report earnings on 2026-08-03, with a consensus EPS estimate of -0.15 USD.